Position in BIIB
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$28,198,422
-$17,330,300 QoQ
Shares Held
130,512
-47.4% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#90
of 1,031 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026THOMPSON SIEGEL & WALMSLEY LLC holds $141,170,482 across 11 Drug Manufacturers - General names. BIIB ranks #2 (20.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
274,133 | $35,226,090 | |
| 2 | BIIB |
Biogen Inc.
This page
|
130,512 | $28,198,422 | |
| 3 | ABBV |
AbbVie Inc.
|
72,426 | $18,225,278 | |
| 4 | PFE |
Pfizer Inc
|
589,575 | $14,196,966 | |
| 5 | AMGN |
Amgen Inc
|
34,760 | $12,587,291 | |
| 6 | JNJ |
Johnson & Johnson
|
41,916 | $10,645,406 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
70,332 | $8,885,744 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
121,984 | $7,028,718 |
All Filings in BIIB
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,198,422 | 130,512 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $45,528,722 | 248,343 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $40,267,743 | 228,807 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $42,926,395 | 306,442 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $40,567,830 | 323,018 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $35,230,279 | 257,456 | Shares | Defined | 2025-05-09 | |
| 2023-12-31 | $101,696 | 393 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $101,004 | 393 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $111,946 | 393 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $122,611 | 441 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $122,121 | 441 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $117,747 | 441 | Shares | Defined | 2022-10-25 | |
| 2022-06-30 | $89,937 | 441 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $92,874 | 441 | Shares | Defined | 2022-04-26 | |
| 2021-12-31 | $105,804 | 441 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $126,213 | 446 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $154,436 | 446 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $128,964 | 461 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $128,061 | 523 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $4,447,534 | 15,678 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,680,518 | 17,494 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $4,688,750 | 14,820 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||